Alphabet Inc. — SEC Form 4 filings
SEC reporting owner CIK 1652044. 11 Form 4 filings on record with FilingPulse; latest filed 2026-07-29.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2025-02-13 to 2026-07-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1,500,000 shares, $4,950,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 17 legs across 7 filings — 2,600,132 shares, $50,186,542 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 1,755,632 shares @ $19.00 ($33,357,008) in Ethos Technologies Inc., filed 2026-01-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Ethos Technologies Inc. (LIFE) | 10% owner | 7 | — | 17 legs · 2,600,132 sh · $50,186,542 | 18 |
| Prime Medicine, Inc. (PRME) | 10% owner | 1 | 1 leg · 1,500,000 sh · $4,950,000 | — | — |
| Starco Brands, Inc. (STCB) | 10% owner | 2 | — | — | 3 |
| Verve Therapeutics, Inc. (VERV) | 10% owner | 1 | — | — | 3 |
Form 4 filings — Alphabet Inc.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-29 | 4 | Ethos Technologies Inc. (LIFE) jointly with GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2021 GP, L.L.C., GV 2021 GP, L.P., GV 2021, L.P. | Other (J): 196,931 @ $0 · Sale (S): 196,931 @ $19.46 · Other (J): 118,138 @ $0 · Sale (S): 118,138 @ $18.90 | EDGAR |
| 2026-07-27 | 4 | Ethos Technologies Inc. (LIFE) jointly with GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2021 GP, L.L.C., GV 2021 GP, L.P., GV 2021, L.P. | Other (J): 63,297 @ $0 · Sale (S): 63,297 @ $19.06 · Other (J): 23,417 @ $0 · Sale (S): 23,417 @ $18.88 | EDGAR |
| 2026-07-23 | 4 | Ethos Technologies Inc. (LIFE) jointly with GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2021 GP, L.L.C., GV 2021 GP, L.P., GV 2021, L.P. | Other (J): 22,900 @ $0 · Sale (S): 22,700 @ $19.05 · Sale (S): 200 @ $19.72 · Other (J): 49,582 @ $0 · Sale (S): 49,582 @ $19.23 | EDGAR |
| 2026-07-21 | 4 | Ethos Technologies Inc. (LIFE) jointly with GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2021 GP, L.L.C., GV 2021 GP, L.P., GV 2021, L.P. | Other (J): 20,534 @ $0 · Sale (S): 20,534 @ $18.68 · Other (J): 18,386 @ $0 · Sale (S): 18,386 @ $18.87 | EDGAR |
| 2026-07-17 | 4 | Ethos Technologies Inc. (LIFE) jointly with GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2021 GP, L.L.C., GV 2021 GP, L.P., GV 2021, L.P. | Other (J): 74,492 @ $0 · Sale (S): 12,500 @ $18.79 · Sale (S): 61,992 @ $19.84 · Other (J): 19,595 @ $0 · Sale (S): 19,595 @ $18.73 | EDGAR |
| 2026-05-18 | 4 | Ethos Technologies Inc. (LIFE) jointly with GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2021 GP, L.L.C., GV 2021 GP, L.P., GV 2021, L.P. | Other (J): 60,077 @ $0 · Sale (S): 60,077 @ $23.01 · Other (J): 87,475 @ $0 · Sale (S): 45,410 @ $23.27 · Sale (S): 42,065 @ $24.27 | EDGAR |
| 2026-01-30 | 4 | Ethos Technologies Inc. (LIFE) jointly with GV 2017 GP, L.L.C., GV 2017 GP, L.P., GV 2017, L.P., GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2021 GP, L.L.C., GV 2021 GP, L.P., GV 2021, L.P. | Conversion (C): 1,755,632 · Conversion (C): 3,287,925 · Conversion (C): 571,907 · Sale (S): 1,755,632 @ $19 · Sale (S): 89,676 @ $19 · Conversion (C): 1,751,791 (derivative) · +2 more | EDGAR |
| 2025-08-05 | 4 | Prime Medicine, Inc. (PRME) jointly with GV 2021 GP, L.L.C., GV 2021 GP, L.P., GV 2021, L.P. | Purchase (P): 1,500,000 @ $3.30 | EDGAR |
| 2025-07-28 | 4 | Verve Therapeutics, Inc. (VERV) jointly with GV 2017 GP, L.L.C., GV 2017 GP, L.P., GV 2017, L.P., GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2023 GP, L.L.C., GV 2023 GP, L.P., GV 2023, L.P. | Code (U): 6,108,442 · Code (U): 4,260,047 · Code (U): 1,800,000 | EDGAR |
| 2025-05-19 | 4 | Starco Brands, Inc. (STCB) jointly with GV 2016 GP, L.L.C., GV 2016 GP, L.P., GV 2016, L.P. | Other (J): 47,980,156 | EDGAR |
| 2025-02-13 | 4 | Starco Brands, Inc. (STCB) jointly with GV 2016 GP, L.L.C., GV 2016 GP, L.P., GV 2016, L.P. | Other (J): 5,675,399 · Other (J): 36,300,393 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1652044 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →